Eric Santa - 22 Mar 2022 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Chief Growth Officer
Signature
By: Nathan A. Smith For: Eric Santa
Issuer symbol
MYGN
Transactions as of
22 Mar 2022
Net transactions value
$0
Form type
4
Filing time
23 Mar 2022, 17:03:19 UTC
Previous filing
18 Feb 2022
Next filing
04 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Award $0 +19,238 +48% $0.000000 59,710 22 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date.